Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Dill

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Nature Cell Biology|October 28, 2016
Corrigendum: The RSPO-LGR4/5-ZNRF3/RNF43 module controls liver zonation and sizeLara Planas-Paz, Vanessa Orsini, Luke Boulter, et al.
Journal of Hepatology|March 3, 2023
Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinomaAinhoa Lapitz, Mikel Azkargorta, Piotr Milkiewicz, et al.
Journal of Hepatology|May 11, 2025
Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trialCynthia Levy, George F Abouda, Bahri M Bilir, et al.
Cell Stem Cell|April 5, 2024
NIBR-LTSi is a selective LATS kinase inhibitor activating YAP signaling and expanding tissue stem cells in vitro and in vivoKenji Namoto, Clara Baader, Vanessa Orsini, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Nature Cell Biology|October 28, 2016
Corrigendum: The RSPO-LGR4/5-ZNRF3/RNF43 module controls liver zonation and sizeLara Planas-Paz, Vanessa Orsini, Luke Boulter, et al.
Journal of Hepatology|March 3, 2023
Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinomaAinhoa Lapitz, Mikel Azkargorta, Piotr Milkiewicz, et al.
Journal of Hepatology|May 11, 2025
Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trialCynthia Levy, George F Abouda, Bahri M Bilir, et al.
Cell Stem Cell|April 5, 2024
NIBR-LTSi is a selective LATS kinase inhibitor activating YAP signaling and expanding tissue stem cells in vitro and in vivoKenji Namoto, Clara Baader, Vanessa Orsini, et al.
Pageof 8